169 related articles for article (PubMed ID: 35851726)
21. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
22. lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma.
Tang G; Luo L; Zhang J; Zhai D; Huang D; Yin J; Zhou Q; Zhang Q; Zheng G
Cancer Lett; 2021 Feb; 498():152-164. PubMed ID: 33130316
[TBL] [Abstract][Full Text] [Related]
23. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S
Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671
[TBL] [Abstract][Full Text] [Related]
24. Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor Prognosis of Glioblastoma.
Bhawe K; Felty Q; Yoo C; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Roy D
Mol Neurobiol; 2020 Sep; 57(9):3827-3845. PubMed ID: 32594352
[TBL] [Abstract][Full Text] [Related]
25. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
[TBL] [Abstract][Full Text] [Related]
26. Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype.
Wu Y; Fletcher M; Gu Z; Wang Q; Costa B; Bertoni A; Man KH; Schlotter M; Felsberg J; Mangei J; Barbus M; Gaupel AC; Wang W; Weiss T; Eils R; Weller M; Liu H; Reifenberger G; Korshunov A; Angel P; Lichter P; Herrmann C; Radlwimmer B
Nat Commun; 2020 Dec; 11(1):6434. PubMed ID: 33339831
[TBL] [Abstract][Full Text] [Related]
27. Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-β1/Smad signaling pathway.
Jiang Y; Zhou J; Hou D; Luo P; Gao H; Ma Y; Chen YS; Li L; Zou D; Zhang H; Zhang Y; Jing Z
J Pathol; 2019 Sep; 249(1):26-38. PubMed ID: 30953361
[TBL] [Abstract][Full Text] [Related]
28. Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in mice.
Bogoch Y; Friedlander-Malik G; Lupu L; Bondar E; Zohar N; Langier S; Ram Z; Nachmany I; Klausner JM; Pencovich N
Tumour Biol; 2017 Apr; 39(4):1010428317698357. PubMed ID: 28443460
[TBL] [Abstract][Full Text] [Related]
29. MiR-154 Functions as a Tumor Suppressor in Glioblastoma by Targeting Wnt5a.
Zhao D; Wang R; Fang J; Ji X; Li J; Chen X; Sun G; Wang Z; Liu W; Wang Y; Cheng G; Zhen H; Sun C; Fei Z
Mol Neurobiol; 2017 May; 54(4):2823-2830. PubMed ID: 27013470
[TBL] [Abstract][Full Text] [Related]
30. Subcellular progression of mesenchymal transition identified by two discrete synchronous cell lines derived from the same glioblastoma.
Kim S; Park SJ; Chowdhury T; Hong JI; Ahn J; Jeong TY; Yu HJ; Shin YK; Ku JL; Park JB; Hur JK; Lee H; Kim K; Park CK
Cell Mol Life Sci; 2022 Mar; 79(3):181. PubMed ID: 35278143
[TBL] [Abstract][Full Text] [Related]
31. Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.
Kling T; Ferrarese R; Ó hAilín D; Johansson P; Heiland DH; Dai F; Vasilikos I; Weyerbrock A; Jörnsten R; Carro MS; Nelander S
EBioMedicine; 2016 Oct; 12():72-85. PubMed ID: 27667176
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
[TBL] [Abstract][Full Text] [Related]
33. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
Frömberg A; Rabe M; Oppermann H; Gaunitz F; Aigner A
BMC Cancer; 2017 Jan; 17(1):3. PubMed ID: 28049521
[TBL] [Abstract][Full Text] [Related]
34. AP-1 Is a Key Regulator of Proinflammatory Cytokine TNFα-mediated Triple-negative Breast Cancer Progression.
Qiao Y; He H; Jonsson P; Sinha I; Zhao C; Dahlman-Wright K
J Biol Chem; 2016 Mar; 291(10):5068-79. PubMed ID: 26792858
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-β1.
Li Q; Cheng Q; Chen Z; Peng R; Chen R; Ma Z; Wan X; Liu J; Meng M; Peng Z; Jiang B
Oncol Rep; 2016 Feb; 35(2):1125-34. PubMed ID: 26717894
[TBL] [Abstract][Full Text] [Related]
36. Tumour necrosis factor alpha induces co-ordinated activation of rat GSH synthetic enzymes via nuclear factor kappaB and activator protein-1.
Yang H; Magilnick N; Ou X; Lu SC
Biochem J; 2005 Oct; 391(Pt 2):399-408. PubMed ID: 16011481
[TBL] [Abstract][Full Text] [Related]
37. A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma.
Cheng WY; Kandel JJ; Yamashiro DJ; Canoll P; Anastassiou D
PLoS One; 2012; 7(4):e34705. PubMed ID: 22493711
[TBL] [Abstract][Full Text] [Related]
38. Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells.
Lamballe F; Toscano S; Conti F; Arechederra M; Baeza N; Figarella-Branger D; Helmbacher F; Maina F
Oncotarget; 2016 Nov; 7(46):74747-74767. PubMed ID: 27732969
[TBL] [Abstract][Full Text] [Related]
39. c-Jun-N-terminal phosphorylation regulates DNMT1 expression and genome wide methylation in gliomas.
Heiland DH; Ferrarese R; Claus R; Dai F; Masilamani AP; Kling E; Weyerbrock A; Kling T; Nelander S; Carro MS
Oncotarget; 2017 Jan; 8(4):6940-6954. PubMed ID: 28036297
[TBL] [Abstract][Full Text] [Related]
40. Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma.
Mikheev AM; Mikheeva SA; Severs LJ; Funk CC; Huang L; McFaline-Figueroa JL; Schwensen J; Trapnell C; Price ND; Wong S; Rostomily RC
Mol Oncol; 2018 Jun; 12(7):1188-1202. PubMed ID: 29754406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]